Hostname: page-component-6bb9c88b65-lm65w Total loading time: 0.006 Render date: 2025-07-23T01:35:35.458Z Has data issue: false hasContentIssue false
  • English
  • Français

Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy

Published online by Cambridge University Press:  03 October 2000

Charlene Butler  and
Suzann Campbell
Charlene Butler
Affiliation:
American Academy for Cerebral Palsy and Developmental Medicine, Rosemont, IL, USA
Suzann Campbell
Affiliation:
American Academy for Cerebral Palsy and Developmental Medicine, Rosemont, IL, USA
Get access

Abstract

The objective of this and other systematic reviews by the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) is to provide the biomedical research and clinical practice communities with current knowledge about evidence supporting various interventions used in the management of developmental disabilities. “Systematic, evidence-based reviews are innovative in their comprehensive review of the literature, use of standard methods of presenting data, and special emphasis on the validity of research methods.” (p.470) AACPDM reviews summarize what is known and not yet known, to identify the gaps in our information about treatment outcomes and to gauge the strength of the internal validity of that evidence.

Information

Type
Annotation
Information
Developmental Medicine and Child Neurology , Volume 42 , Issue 9 , September 2000 , pp. 634 - 645
Copyright
© 2000 Mac Keith Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable